Companies that have rejected hierarchies have typically lacked diversity and, in at least one case, faced scandal. A new crop of them is aiming to find a middle ground.
Category: Theranos Inc
-
Elizabeth Holmes Says She Can’t Afford $250 Payments to Theranos Victims
Elizabeth Holmes, the founder of a blood-testing company, was ordered to pay $250 a month to defrauded investors after her prison term. Her lawyers said she had “limited financial resources.”
-
Elizabeth Holmes Set to Report to Prison Tuesday in Texas
The disgraced founder of the blood testing start-up Theranos, who was convicted of fraud, is expected to report to a minimum-security prison in Texas.
-
Elizabeth Holmes Must Report to Prison on May 30
The Theranos founder, who was convicted last year of defrauding investors, lost her bid to remain free on bail while she appeals her conviction.
-
Corporate Bankruptcies Are Set to Reach a Decade-Long High
New data shows that 2023 is shaping up to be the biggest year for Chapter 11 filings in more than a decade.
-
Debt-Ceiling Déjà Vu Worries Wall Street
The last crisis, in 2011, led to a credit downgrade that sank stocks. This time, Treasury Secretary Janet Yellen has warned of a “financial catastrophe.”
-
Europe Plots a Diplomatic and Business Reset on China
President Emmanuel Macron of France and Ursula von der Leyen, President of the European Commission, arrived in China on Wednesday aiming to restart business and political ties.
-
The Numbers in the News
The New York Times – Business:DealBook looks at the data points behind some of the biggest stories of the past year, and the themes that will endure in 2023.
-
Ramesh Balwani, No. 2 Theranos Executive, Is Sentenced for Fraud
The New York Times – Business:Ramesh Balwani, the former chief operating officer of the failed blood testing start-up, was convicted of 12 counts of fraud in July.
-
Elizabeth Holmes Is Sentenced to More Than 11 Years for Fraud
The New York Times – Business:Ms. Holmes was convicted in January of four counts of wire fraud for deceiving investors with claims about her blood testing start-up Theranos.